Security key
48115J109
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 2,360,259
- Share change
- +543,874
- Total reported value
- $13,310,203
- Price per share
- $5.64
- Number of holders
- 35
- Value change
- +$3,384,583
- Number of buys
- 19
- Number of sells
- 16
Report period
Q2 2024
Institutions
35
Top holders
10
DERM full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Ownership snapshot
Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
VANGUARD GROUP INC
13D/G signal
—
Evidence rows
34
Latest as of
31 Mar 2024
13F
3/4/5
Lead comparable stake: 1.5%
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
1.5%
|
$1,141,713
310,248 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.3%
|
$996,000
270,600 shares
|
— | 31 Mar 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1%
|
$817,000
222,663 shares
|
— | 31 Mar 2024 |
| AMERICAN FINANCIAL GROUP INC |
13F
Company
|
0.84%
|
$662,000
180,000 shares
|
— | 31 Mar 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
0.65%
|
$510,140
138,625 shares
|
— | 31 Mar 2024 |
| Walleye Capital LLC |
13F
Company
|
0.63%
|
$494,577
134,396 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.42%
|
$327,876
89,075 shares
|
— | 31 Mar 2024 |
| Neuberger Berman Group LLC |
13F
Company
|
0.38%
|
$299,530
81,394 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
0.23%
|
$181,825
49,409 shares
|
— | 31 Mar 2024 |
| XTX Topco Ltd |
13F
Company
|
0.17%
|
$134,497
36,548 shares
|
— | 31 Mar 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.17%
|
$132,911
36,117 shares
|
— | 31 Mar 2024 |
| Heron Bay Capital Management |
13F
Company
|
0.16%
|
$123,902
33,669 shares
|
— | 31 Mar 2024 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
0.14%
|
$106,628
28,975 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
0.12%
|
$94,035
25,553 shares
|
— | 31 Mar 2024 |
| BRIGHTON JONES LLC |
13F
Company
|
0.11%
|
$84,714
23,020 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.11%
|
$83,374
22,656 shares
|
— | 31 Mar 2024 |
| PERKINS CAPITAL MANAGEMENT INC |
13F
Company
|
0.1%
|
$81,000
22,000 shares
|
— | 31 Mar 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.09%
|
$73,471
19,965 shares
|
— | 31 Mar 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.08%
|
$64,967
17,654 shares
|
— | 31 Mar 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.07%
|
$55,421
15,060 shares
|
— | 31 Mar 2024 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
0.06%
|
$46,567
12,654 shares
|
— | 31 Mar 2024 |
| NWAM LLC |
13F
Company
|
0.06%
|
$40,661
11,820 shares
|
— | 31 Mar 2024 |
| Creative Planning |
13F
Company
|
0.06%
|
$43,292
11,764 shares
|
— | 31 Mar 2024 |
| Allegiance Financial Group Advisory Services LLC |
13F
Company
|
0.05%
|
$36,800
10,000 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.02%
|
$18,540
5,038 shares
|
— | 31 Mar 2024 |
| IFP Advisors, Inc |
13F
Company
|
0.02%
|
$12,523
3,403 shares
|
— | 31 Mar 2024 |
| NewEdge Advisors, LLC |
13F
Company
|
0.01%
|
$7,815
2,124 shares
|
— | 31 Mar 2024 |
| FEDERATED HERMES, INC. |
13F
Company
|
0.01%
|
$4,891
1,329 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$2,024
550 shares
|
— | 31 Mar 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$224
61 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0%
|
$55
15 shares
|
— | 31 Mar 2024 |
| Fortress Biotech, Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$11,735,820
3,860,467 shares
|
— | 12 May 2022 |
| Ernest Robert de Paolantonio |
3/4/5
Officer
|
—
class O/S missing
|
$1,356,715
259,907 shares
|
— | 04 Oct 2022 |
| Jeffrey Paley |
3/4/5
Director
|
—
class O/S missing
|
$369,195
70,727 shares
|
— | 28 Nov 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
35
Shares
2,360,259
Rows loaded
35
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
31
Q2 2024 holders
35
Holder diff
4
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.